Atossa Therapeutics (ATOS) Capital Expenditures (2011 - 2025)
Atossa Therapeutics (ATOS) posted Capital Expenditures of $7,000 for Q4 2025, unchanged from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Capital Expenditures (2011 - 2025) Analysis & Trends
For FY2025, Atossa Therapeutics' Capital Expenditures came in at $23,000, up 21.1% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 20.6% (FY2020 to FY2025).
- In prior years, Atossa Therapeutics' Capital Expenditures was $19,000 in FY2024 (+35.7%), $14,000 in FY2023 (-48.1%), $27,000 in FY2022 (+200.0%) and $9,000 in FY2021 (unchanged).
- Quarterly Capital Expenditures has run from a low of $1,000 in Q3 2023 to a high of $13,000 in Q2 2023 over five years.
- On a year-over-year basis, Capital Expenditures increased in two of the last four quarters, with growth averaging 210.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Atossa Therapeutics | 19.46 Mn | 19.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Dec 31, 2020 | -367.00 |
| Sep 30, 2020 | 2,757.00 |
| Dec 31, 2018 | 56,458.00 |
| Sep 30, 2018 | 2,957.00 |
| Jun 30, 2018 | 423.00 |
| Mar 31, 2018 | 51,068.00 |
| Sep 30, 2016 | 82.00 |
| Jun 30, 2016 | -79.00 |
API Access
Atossa Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();